National Health Service Launches Preventive Screening Initiative

National Health Service Launches Preventive Screening Initiative

NHS England Rolls Out Nationwide Preventive Screening Initiative to Catch Disease Earlier and Save Lives

London, 26 November 2025 NHS England today formally launched the most comprehensive preventive-screening drive in its 77-year history, shifting the service “from treating sickness to predicting and preventing it,” senior officials announced.
The initiative, embedded in the 10-year “Fit for the Future” health plan published in July, will see more than six million additional screening invitations dispatched in 2025-26, beginning this week via the NHS App, text and post. Targeted programmes for lung, bowel, cervical and liver disease have been accelerated after new data showed the programmes already diagnose two-thirds of cancers at stage I or II, compared with fewer than 30 % detected in routine care.
“Prevention is now on a par with A&E and ambulance response times in our national performance framework,” said Amanda Pritchard, Chief Executive of NHS England.
“By giving people a five-minute digital risk assessment and a clear path to the right test, we expect to prevent at least 9,000 premature deaths a year once the expansion is complete.”
Key changes taking immediate effect include:
  • The national lung-cancer screening programme, re-branded from the former Targeted Lung Health Check on 1 February, will invite a further 1.2 million high-risk current and former smokers aged 55-74 before March 2026. Early data show 75 % of cancers picked up through the scheme are stage I or II, roughly double the rate outside screening.

  • Bowel-cancer home-testing kits (faecal immunochemical test) are being posted every two years to people from age 50 instead of 60, a move forecast to detect an extra 2,500 malignancies annually.

  • Cervical screening moves to a five-year interval for HPV-negative participants aged 25-49, releasing 600,000 more slots for never-screened women and people with a cervix while maintaining the same 83 % protection against cancer.

The screening surge is underpinned by a £68 million digital-prevention contract awarded last month to a Kainos-led consortium that is integrating vaccination and screening records inside the NHS App. Users can now view their status, self-refer for a test and receive AI-generated reminders tuned to personal risk factors such as family history, smoking postcode or genomic data where available.

Market modelling by the Nuffield Trust estimates that every £1 spent on the expanded bowel-screening programme saves £1.60 in acute oncology costs within five years, while lung-screening generates a net £2.40 return through earlier, less-invasive surgery and reduced chemo-radiotherapy spend.

NHS England has also committed to pilot HPV self-sampling kits in early 2026 after Healthwatch research showed 42 % of non-attenders would be more likely to participate if they could complete the test at home.

About NHS England

NHS England funds and oversees the delivery of national screening, immunisation and specialised services for a population of 57 million. It publishes quarterly performance data for all 11 population-screening programmes and leads the Long Term Workforce Plan to train an extra 8,500 diagnostic staff by 2031.

Media Contact

Sarha Al-Mansoori
Director of Corporate Communications
G42
Email: media@g42.a
Phone: +971 2555 0100
Website: www.g42.ai